The 2013 International Society for Heart and Lung Transplantation Working Formulation for the standardization of nomenclature in the pathologic diagnosis of antibody-mediated rejection in heart transplantation JOURNAL OF HEART AND LUNG TRANSPLANTATION Berry, G. J., Burke, M. M., Andersen, C., Bruneval, P., Fedrigo, M., Fishbein, M. C., Goddard, M., Hammond, E. H., Leone, O., Marboe, C., Miller, D., Neil, D. L., Rassl, D., Revelo, M. P., Rice, A., Rodriguez, E. R., Stewart, S., Tan, C. D., Winters, G. L., West, L., Mehra, M. R., Angelini, A. L. 2013; 32 (12): 1147-1162


During the last 25 years, antibody-mediated rejection of the cardiac allograft has evolved from a relatively obscure concept to a recognized clinical complication in the management of heart transplant patients. Herein we report the consensus findings from a series of meetings held between 2010-2012 to develop a Working Formulation for the pathologic diagnosis, grading, and reporting of cardiac antibody-mediated rejection. The diagnostic criteria for its morphologic and immunopathologic components are enumerated, illustrated, and described in detail. Numerous challenges and unresolved clinical, immunologic, and pathologic questions remain to which a Working Formulation may facilitate answers.

View details for DOI 10.1016/j.healun.2013.08.011

View details for PubMedID 24263017